455 related articles for article (PubMed ID: 34016721)
41. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.
David G; Morvan M; Gagne K; Kerdudou N; Willem C; Devys A; Bonneville M; Folléa G; Bignon JD; Retière C
Immunology; 2009 Oct; 128(2):172-84. PubMed ID: 19740374
[TBL] [Abstract][Full Text] [Related]
42. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells.
Joncker NT; Raulet DH
Immunol Rev; 2008 Aug; 224():85-97. PubMed ID: 18759922
[TBL] [Abstract][Full Text] [Related]
43. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
[TBL] [Abstract][Full Text] [Related]
44. MHC class I-independent recognition of NK-activating receptor KIR2DS4.
Katz G; Gazit R; Arnon TI; Gonen-Gross T; Tarcic G; Markel G; Gruda R; Achdout H; Drize O; Merims S; Mandelboim O
J Immunol; 2004 Aug; 173(3):1819-25. PubMed ID: 15265913
[TBL] [Abstract][Full Text] [Related]
45. A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
Zhou H; Luo Y; Kaplan CD; Krüger JA; Lee SH; Xiang R; Reisfeld RA
Blood; 2006 Apr; 107(8):3251-7. PubMed ID: 16368879
[TBL] [Abstract][Full Text] [Related]
46. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
47. The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.
van Bergen J; Koning F
Immunology; 2010 Nov; 131(3):301-9. PubMed ID: 20722764
[TBL] [Abstract][Full Text] [Related]
48. HLA and KIR polymorphisms affect NK-cell anti-tumor activity.
Passweg JR; Huard B; Tiercy JM; Roosnek E
Trends Immunol; 2007 Oct; 28(10):437-41. PubMed ID: 17825623
[TBL] [Abstract][Full Text] [Related]
49. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
[TBL] [Abstract][Full Text] [Related]
50. Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype.
Tiemessen CT; Paximadis M; Minevich G; Winchester R; Shalekoff S; Gray GE; Sherman GG; Coovadia AH; Kuhn L
J Acquir Immune Defic Syndr; 2011 Jul; 57(3):181-9. PubMed ID: 21407082
[TBL] [Abstract][Full Text] [Related]
51. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
Gooneratne SL; Center RJ; Kent SJ; Parsons MS
Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
[TBL] [Abstract][Full Text] [Related]
52. KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation.
Huard B; Karlsson L; Triebel F
Eur J Immunol; 2001 Jun; 31(6):1728-35. PubMed ID: 11385617
[TBL] [Abstract][Full Text] [Related]
53. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes.
Zambello R; Falco M; Della Chiesa M; Trentin L; Carollo D; Castriconi R; Cannas G; Carlomagno S; Cabrelle A; Lamy T; Agostini C; Moretta A; Semenzato G; Vitale M
Blood; 2003 Sep; 102(5):1797-805. PubMed ID: 12750175
[TBL] [Abstract][Full Text] [Related]
54. The killer-cell immunoglobulin-like receptors of macaques.
Bimber BN; Evans DT
Immunol Rev; 2015 Sep; 267(1):246-58. PubMed ID: 26284482
[TBL] [Abstract][Full Text] [Related]
55. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
[TBL] [Abstract][Full Text] [Related]
56. Structure and function of natural killer cell surface receptors.
Radaev S; Sun PD
Annu Rev Biophys Biomol Struct; 2003; 32():93-114. PubMed ID: 12471063
[TBL] [Abstract][Full Text] [Related]
57. Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.
Cooley S; Parham P; Miller JS
Blood; 2018 Mar; 131(10):1053-1062. PubMed ID: 29358179
[TBL] [Abstract][Full Text] [Related]
58. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.
Béziat V; Liu LL; Malmberg JA; Ivarsson MA; Sohlberg E; Björklund AT; Retière C; Sverremark-Ekström E; Traherne J; Ljungman P; Schaffer M; Price DA; Trowsdale J; Michaëlsson J; Ljunggren HG; Malmberg KJ
Blood; 2013 Apr; 121(14):2678-88. PubMed ID: 23325834
[TBL] [Abstract][Full Text] [Related]
59. Molecular Signatures of Natural Killer Cells in CMV-Associated Anterior Uveitis, A New Type of CMV-Induced Disease in Immunocompetent Individuals.
Yawata N; Shirane M; Woon K; Lim X; Tanaka H; Kawano YI; Yawata M; Chee SP; Siak J; Sonoda KH
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807229
[TBL] [Abstract][Full Text] [Related]
60. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms.
Snyder MR; Nakajima T; Leibson PJ; Weyand CM; Goronzy JJ
J Immunol; 2004 Sep; 173(6):3725-31. PubMed ID: 15356118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
